Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has issued an announcement.
Dawnrays Pharmaceutical Holdings Ltd. announced an interim cash dividend of HKD 0.015 per share for the six months ending June 30, 2025. The ex-dividend date is set for September 16, 2025, with the payment date scheduled for October 3, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may influence investor sentiment positively.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company is primarily engaged in providing a range of medical solutions, with a market focus on delivering high-quality healthcare products.
Average Trading Volume: 2,258,459
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$1.97B
See more data about 2348 stock on TipRanks’ Stock Analysis page.